Attenuated physical exercise capacity in smokers compared with non-smokers after coronary angioplasty despite similar

B Jørgensen1, K Endresen, K Forfang

  • 1Department of Cardiology, University of Oslo, Norway.

European Heart Journal
|August 26, 1998
PubMed

Insights

Smokers experienced a lower increase in exercise capacity after percutaneous transluminal coronary angioplasty compared to non-smokers. This indicates that smoking may attenuate the clinical benefits of this coronary intervention.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Exercise Physiology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for treating coronary artery disease.
  • Smoking is a major risk factor for cardiovascular disease and may impact treatment outcomes.
  • Understanding the influence of smoking on recovery after PTCA is crucial for patient management.

Purpose of the Study:

  • To investigate the effect of smoking on exercise capacity changes following PTCA.
  • To compare the recovery of exercise capacity between smokers and non-smokers post-PTCA.

Main Methods:

  • 368 men under 70 eligible for PTCA were enrolled; 334 completed the study.
  • Exercise tests were conducted pre-PTCA and at 2 and 19 weeks post-PTCA.
  • Coronary angiography was performed, and angiograms were quantitatively analyzed.

Main Results:

  • Smokers were younger than non-smokers (52.4 vs 55.7 years).
  • Initial exercise capacity was similar between smokers and non-smokers.
  • Non-smokers showed a significantly greater increase in exercise capacity at both 2 and 19 weeks post-PTCA compared to smokers.

Conclusions:

  • Both smokers and non-smokers derived clinical benefit from PTCA, as assessed by exercise testing.
  • Smokers exhibited a significantly attenuated increase in exercise capacity post-PTCA.
  • Smoking appears to reduce the exercise capacity benefits gained from percutaneous transluminal coronary angioplasty.
Abstract

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
373
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
324
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
646
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
358
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
2.4K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.8K